Goldman Sachs initiates Royalty Pharma stock with Buy rating, $42 target

1 month ago 13
Read Entire Article
  1. Homepage
  2. Finance
  3. Goldman Sachs initiates Royalty Pharma stock with Buy rating, $42 target

Related

JPMorgan downgrades Lenovo stock to Neutral on memory price concerns

JPMorgan downgrades Lenovo stock to Neutral on memory price ...

6 minutes ago 0
Morgan Stanley downgrades Bath & Body Works stock on growth concerns

Morgan Stanley downgrades Bath & Body Works stock on growth ...

6 minutes ago 0
Eugene Technology stock initiated at Outperform by Macquarie on DRAM growth

Eugene Technology stock initiated at Outperform by Macquarie...

6 minutes ago 0

Trending

1. tanzania
2. the 100
3. everlane
4. las vegas weather
5. flash flood warning
6. accident attorneys
7. jake weatherald
8. nurse practitioner
9. auto accident attorneys
10. big bear weather

Popular

College football by the odds: Vegas picks and preview of Ohio State vs. Notre Dame

College football by the odds: Vegas picks and preview of Ohi...

10 months ago 606
What is Tren de Aragua, the Venezuelan gang targeted by Trump?

What is Tren de Aragua, the Venezuelan gang targeted by Trum...

8 months ago 479
Taiwan slightly cuts 2025 GDP growth outlook amid Trump tariffs concern

Taiwan slightly cuts 2025 GDP growth outlook amid Trump tari...

8 months ago 327
What to do in Las Vegas this week: January 2-8

What to do in Las Vegas this week: January 2-8

10 months ago 297
Australian whose blood saved 2.4 million babies dies

Australian whose blood saved 2.4 million babies dies

8 months ago 285
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

© Sincity Press 2025. All rights are reserved